Christmas Cheer from Bionomics?

  1. 5,413 Posts.
    lightbulb Created with Sketch. 1161
    Happy Christmas shareholders...............................

    Wouldn't it be a great surprise if good old BNO made a positive announcement on its progress with the oncology assets sale!

    Wouldn't it be great if we got details about the level of buying interest and the likely price that such transactions could achieve?

    Wouldn't it be great if we got some idea about how long this sale process will take?

    Wouldn't it be great if we got an update on progress with trials and evaluations on the Alzheimers drug that we have licensed to Merck?

    Wouldn't it be great if we got an update on recruitment for the BNC 210 PTSD trial?

    So much potential good news at Christmas , and yet our company still does not seem to understand that the markets need positive news in order to maintain let alone stimulate buyer interest.

    Needless to say, if there is nothing to say, then they should say nothing.

    If there is nothing to say, then I would suggest that they are taking their salaries under false pretenses - because there SHOULD be some news from the company (given the salary levels) - if only an update on the above and any other newsworthy developments that might be relevant for shareholders.

    Come on Bionomics - you CAN DO BETTER in relation to investor communications!

    Surely the Board must be frustrated with the share price?

    Surely the Board has SOME idea on how to have the value of the company better reflected in the share price.

    DO they want us to vote against the REM report or what?

    Current performance rating is "P" - on my scale of marking performance a "P" stands for pathetic - which is one notch lower than "C" (which stands for "Can do Better").

    Who know's maybe posts like this will stir up the old possum?

    We can only hope!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.